Gabriel C. Caponetti

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Guido Ghilardi, Joseph A. Fraietta, James N. Gerson et al. · Nature Medicine · 2024 · 231 citations

Lymphoid Neoplasia, Radiation Oncology, Cancer Immunosurveillance +10

Evaluation of Immunohistochemistry in Identifying Bartonella henselae in Cat-Scratch Disease

Gabriel C. Caponetti, Liron Pantanowitz, Sharon Marconi et al. · American Journal of Clinical Pathology · 2009 · 67 citations · Full text

Zoonotic Disease, Pathogenesis, Histopathology +15

Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Basem M. William, Maribeth Hohenstein, Fausto R. Loberiza et al. · Blood · 2010 · 21 citations

HIV-associated Lymphadenopathy

Gabriel C. Caponetti, Liron Pantanowitz · Ear Nose & Throat Journal · 2008 · 17 citations · Full text

Isolated<i>MYC</i>cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

Gabriel C. Caponetti, Bhavana J. Davé, Anamarija M. Perry et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 16 citations

Hematological Malignancy, Bcl6 Gene Abnormalities, Lymphoid Neoplasia +11